Cutaneous lesions of dermatomyositis with supervening fibrosis

Journal of Cutaneous Pathology

Volumn 35, Issue 1, 2008, Pages 31-39

  Magro, Cynthia M ^a   Dyrsen, Molly ^a   Kerns, Mary Jo ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Wright State Medical Centre   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATITIS; DERMATOMYOSITIS; ENDOTHELIUM INJURY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; LUNG FIBROSIS; MALE; MUSCLE DISEASE; SCLERODERMA; SKIN BIOPSY; SKIN DEFECT; WESTERN BLOTTING;

ADULT; BIOLOGICAL MARKERS; BIOPSY; CHILD, PRESCHOOL; COMPLEMENT MEMBRANE ATTACK COMPLEX; DERMATOMYOSITIS; ENDOTHELIUM, VASCULAR; FEMALE; FIBROSIS; HUMANS; INFANT; MALE; MIDDLE AGED; MUCINS; MUSCLE, SKELETAL; PROGNOSIS; PULMONARY FIBROSIS; SCLEROSIS; SKIN;

EID: 37249054344     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2007.00770.x     Document Type: Article

References (39)

1. Crowson AN, Magro CM. The role of microvascular injury in the pathogenesis of cutaneous lesions of dermatomyositis. Hum Pathol 1996 27: 15.
2. Magro CM, Crowson AN. The immunofluorescent profile of dermatomyositis: a comparative study with lupus erythematosus. J Cutan Pathol 1997 24: 543.
3. High WA, Aranda J, Patel SB, et al. Is Degos disease a clinical and histologic end point rather than a specific disease? J Am Acad Dermatol 2004 50: 895.
4. Kang EH, Lee EB, Shin KC, et al. Interstitial lung disease in patients with polymyositis, dermatomyositis, and amyopathic dermatomyositis. Rheumatology (Oxford) 2005 44: 1282.
5. Friedman AW, Targoff IN, Arnett FC. Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in absence of clinically apparent myositis. Semin Arthritis Rheum 1996 26: 459.
6. Tsao H, Busam K, Barnhill RL, Haynes HA. Lesions resembling malignant atrophic papulosis in a patient with dermatomyositis. J Am Acad Dermatol 1997 36: 317.
7. Tazelaar HD, Viggiano RW, Pickersgill J, et al. Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis 1990 141: 727.
8. Nobutoh T, Khoda M, Doi Y, et al. An autopsy case of dermatomyositis with rapidly progressive diffuse alveolar damage. J Dermatol 1998 25: 32.
9. Ferri C, Valentini G, Cozzi F, et al. Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine 2002 81: 139.
10. Vandergheynst F, Ocmant A, Sordet C, et al. Anti-pm/scl antibodies in connective tissue disease: clinical and biological assessment of 14 patients. Clin Exp Rheumatol 2006 24: 129.
11. Blaszczyk M, Jablonska S, Szymanska-Jagiello W, et al. Child scleromyositis: an overlap syndrome associated with PM-Scl antibody. Ped Dermatol 1991 8: 1.
12. Mimori T. Scleroderma-polymyositis overlap syndrome: clinical and serologic aspects. Int J Dermatol 1987 26: 419.
13. Garcia-Patos V, Bartralot R, Folollosa V, et al. Childhood sclerodermatomyositis: report of a case with anti-PM/Scl antibody and mechanic's hands. Br J Dermatol 1996 135: 613.
14. Kamei N, Yamane K, Yamashita Y, et al. Anti-Ku antibody-positive scleroderma-dermatomyositis overlap syndrome developing Graves' disease and immune thrombocytopenic purpura. Intern Med 2002 41: 1199.
15. Tuffanelli DL, Winkelmann RK. Systemic scleroderma, a clinical study of 727 cases. Arch Dermatol 1961 84: 359.
16. Tuffanelli DL. Scleroderma and its relationship to the "collagenoses": dermatomyositis, lupus erythematosus, rheumatoid arthritis and Sjogren's syndrome. Am J Med Sci 1962 243: 133.
17. Marguerie C, Bunn CC, Copier J, et al. The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-Scl. Medicine 1992 71: 327.
18. Hietarinta M, Meyer O, Haim T, et al. Antinuclear and antinucleolar antibodies in patients with scleroderma-polymyositis overlap syndrome. Br J Rheumatol 1996 35: 1326.
19. Park JH, Lee CW. Concurrent development of dermatomyositis and morphoea profunda. Clin Exp Dermatol 2002 27: 324.
20. Andrews J, Hall MA. Dermatomyositis-scleroderma overlap syndrome presenting as autoimmune haemolytic anaemia. Rheumatology (Oxford) 2002 41: 956.
21. Marschalko M, Ponyai G, Ablonczy E, Horvath A. Dermatomyositis: clinical study of 34 patients. Orv Hetil 2000 141: 225.
22. Oya Y, Toyama J, Ogawa M, et al. A patient with dermatomyositis and systemic sclerosis with preferential facioscapulohumeral muscle involvement and fatal cardiomyopathy. Rinsho Shinkeigaku 2001 41: 289.
23. Kubo N, Sawayama Y, Okada K, et al. A case of amyopathic dermatomyositis with systemic sclerosis sine scleroderma presenting abnormal vermiculation. Ryumachi 2002 42: 676.
24. Karube M, Kaneda F, Nakabayashi K, et al. Pneumatosis cystoides intestinalis in overlap syndrome manifested by dermatomyositis and scleroderma. Nippon Naika Gakkai Zasshi 2002 91: 3278.
25. Torok L, Danko K, Cserni G, Szucs G. Polymyositis/scleroderma autoantibody-positive scleroderma with dermatomyositis (scleromyositis). Orv Hetil 2002 143: 2553.
26. Magro CM, Calomeni EP, Nadasdy T, Shusterman BD, Pope-Harman A, Ross P Jr. Ultrastruct Pathol 2005 29: 95.
27. Dalakas MC, Sivakumar K. The immunopathologic and inflammatory differences between dermatomyositis, polymyositis and sporadic inclusion body myositis. Curr Opin Neurol 1996 9: 235.
28. Magro CM, Waldman WJ, Knight DA, et al. Idiopathic pulmonary fibrosis related to endothelial injury and antiendothelial cell antibodies. Hum Immunol 2006 67: 284.
29. Miyazaki E, Ando M, Muramatsu T, et al. Early assessment of rapidly progressive interstitial pneumonia associated with amyopathic dermatitis. Clin Rheumatol 2005 20: 1.
30. Selva-O'Callaghan A, Labrador-Horrillo M, Munoz-Gall X, et al. Polymyositis/dermatomyositis-associated lung disease: analysis of a series of 81 patients. Lupus 2005 14: 534.
31. Yokoyama T, Sakamoto T, Shida, et al. Fatal rapidly progressive interstitial pneumonitis associated with amyopathic dermatomyositis and CD8 T lymphocytes. J Intensive Care Med 2005 20: 160.
32. Magro, CM, Nuovo G, Ferri C, et al. Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma. J Cutan Pathol 2004 31: 43.
33. Wusirika R, Ferri C, Marin M, et al. The assessment of anti-endothelial antibodies in scleroderma-associated pulmonary fibrosis. A study of indirect immunofluorescent and western blot analysis in 49 patients with scleroderma. Am J Clin Pathol 2003 120: 596.
34. Kissel JT, Mendell JR, Rammohan KW. Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med 1986 314: 329.
35. Targoff IN. Humoral immunity in polymyositis/dermatomyositis. J Invest Dermatol 1993 100: 1165.
36. Targoff IN. Polymyositis. In Reichlin M, Bigazzi P, eds. Systemic autoimmunity. New York: Marcel Dekker Inc., 1991 201.
37. Targoff IN. Immune mechanisms in myositis. Curr Opin Rheumatol 1990 2: 882.
38. Funauchi M, Shimadsu H, Tamaki C, et al. Role of endothelial damage in the pathogenesis of interstitial pneumonitis in patients with polymyositis and dermatomyositis. J Rheumatol 2006 33: 903.
39. Magro C, et al. The role of microvascular injury in the pathogenesis of pulmonary fibrosis of collagen vascular disease. Am J Clin Pathol in press 2007 127: 237.